All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
Mon 1984-11-05? to Fri 2025-01-10 |
YTD
Return |
TRR
Price |
||||
---|---|---|---|---|---|---|
GSK × |
−2.25%
2025-01-10 |
15.07 TRR
2025-01-10 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-01-10 |
Overall
Return |
Exponential
Trendline |
||||
---|---|---|---|---|---|---|
GSK × |
+1,406.83%
+6.98%/yr |
+5.25%/yr
(R2=0.683) |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Mon 1984-11-05? to Fri 2025-01-10 |
Start
Value |
End
Value |
||||
---|---|---|---|---|---|---|
GSK × |
$10,000.00
1984-11-05 |
$150,683.06
2025-01-10 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||
Year | GSK |
---|---|
2025 (YTD) | −2.25% |
2024 | −7.97% |
2023 | +6.18% |
2022 | −23.24% |
2021 | +18.30% |
2020 | −18.88% |
2019 | +26.26% |
2018 | +11.53% |
2017 | −5.06% |
2016 | −0.09% |
2015 | −1.10% |
2014 | −16.39% |
2013 | +26.92% |
2012 | −1.18% |
2011 | +18.96% |
2010 | −3.65% |
2009 | +16.07% |
2008 | −22.41% |
2007 | −4.72% |
2006 | +5.21% |
2005 | +6.18% |
2004 | +2.22% |
2003 | +26.27% |
2002 | −23.47% |
2001 | −11.04% |
2000 | +0.69% |
1999 | −20.11% |
1998 | +45.80% |
1997 | +53.12% |
1996 | +14.04% |
1995 | +41.55% |
1994 | +0.33% |
1993 | −12.83% |
1992 | −25.15% |
1991 | +92.92% |
1990 | +22.86% |
1989 | +32.51% |
1988 | +2.43% |
1987 | +15.34% |
1986 | +37.65% |
1985 | +68.43% |
1984 | −1.91% |
Mon 1984-11-05? to Fri 2025-01-10 |
Current
Drawdown |
Worst
Drawdown |
||||
---|---|---|---|---|---|---|
GSK × | −30.82% |
−60.55%
2009-03-09 |
||||
GlaxoSmithKline PLC ADR NYSE Common Stock | ||||||